HOME >> BIOLOGY >> NEWS
Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Glucosidase inhibitors may have a future as broad-based hepatitis drugs Researchers at Jefferson Medical College may have found a promising drug against the hepatitis C virus (HCV). While they are quick to point out that the drug, N-nonyl-DNJ, stopped only a surrogate virus - and not the actual HCV - from reproducing in the laboratory, they believe the findings, which build on their earlier success against hepatitis B virus (HBV), may someday lead to a single drug against both viruses.

Timothy Block, Ph.D., professor of biochemistry and molecular pharmacology and medicine at Thomas Jefferson University in Philadelphia, and colleagues at Oxford University in Oxford, UK, used the drug to inhibit the activity of an important cellular enzyme, glucosidase. This in turn prevented the bovine diarrhea virus, BVDV, which is a tissue culture model of HCV, from making more virus. Dr. Block believes this class of drugs, called glucosidase inhibitors, "have a reasonable likelihood of working against HCV therapeutically." Because HCV cannot be grown in the lab, researchers use BVDV as a testing model.

"This is the first drug since alpha-interferon to my knowledge for which there is published experimental evidence against HCV - in the form of BVDV susceptibility," says Dr. Block, who is a member of Jefferson's Kimmel Cancer Center and director of the Jefferson Center for Biomedical Research and Agricultural Medicine.

The drug may sidestep resistant viruses, the bane of current anti-hepatitis treatments. "Since the drugs target a host cellular enzyme at very non-toxic doses, rather than the virus, we think that resistance to the drugs will not be a problem,"he says.

The findings appear Oct. 12 in the Proceedings of the National Academy of Sciences. Viruses such as HCV, HBV and BVDV reproduce by actually "budding out from intracellular membranes." The viruses
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
11-Oct-1999


Page: 1 2 3

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists propose mechanism to control the bodys red blood cell and platelet production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... MEXICO CITY (PRWEB) , ... June 05, 2019 ... ... temperature-controlled packaging, announces the opening of a new network station and service center ... America — and 12th in the world — with more than $1.75 billion ...
(Date:6/4/2019)... ... June 04, 2019 , ... Most preclinical EEG ... seizure risk signals, usually based on variations of amplitude, frequency or spike train ... diagnostic methodology due to the complexity and variability of the signal, and automation ...
(Date:5/31/2019)... ... May 30, 2019 , ... ... and Mayo Clinic, have documented significant differences in the prevalence of hereditary genetic ... populations compared to non-Hispanic White women. Results will be presented at the 2019 ...
Breaking Biology News(10 mins):
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ... device industries, announced today that they will be receiving 3 awards at the 2019 ... WCCT received 2 awards in the categories of overall Quality and Compatibility (Access to ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... is pleased to announce the strategic acquisition of Metabiologics, Inc., a globally recognized ... provides Object exclusive ownership and commercialization rights to a full spectrum of botulinum ...
(Date:5/15/2019)... ... ... Milton Hershey School® has named William Charles Ballough Harding ’78 the 2019 ... he is changing lives by creating solutions to global healthcare challenges through the development ... our founders – Milton and Catherine Hershey – who always hoped for Milton Hershey ...
(Date:5/8/2019)... ... May 07, 2019 , ... Standing at 16.2 hands, Atlas is on the large side ... drill team and barrel racing, among other activities. When loping around a corner in ... from being a busy horse to only being able to walk. Fortunately Atlas’ owner, ...
Breaking Biology Technology:
Cached News: